RNA, U6atac small nuclear 31, pseudogene (RNU6ATAC31P)

RNU6ATAC31P is annotated as a pseudogene of the U6atac small nuclear RNA family[4]. U6atac is a component of the minor (U12-type) spliceosome, a ribonucleoprotein complex essential for pre-mRNA splicing, but RNU6ATAC31P lacks protein-coding capacity and is not transcribed into a functional RNA product[1][4]. As a processed pseudogene, it is the result of a reverse transcription event—often mediated by LINE-1 retroelements—where the original RNA transcript is copied back into DNA and inserted elsewhere in the genome, but lacks the regulatory elements or intact sequence necessary for biological activity[1]. Pseudogenes of U6/U6atac are common in mammalian genomes and have been used as markers to study retrotransposon activity and genome evolution, but they do not serve as drug targets, receptors, or have direct functional or regulatory roles in cell biology or disease[1]. Summary of critical facts: - RNU6ATAC31P is a noncoding pseudogene; not a receptor, enzyme, transporter, or direct drug target. - No evidence it is implicated as a biomarker, disease gene, or relevant to therapeutic targeting. - Description and available data are consistent with standard annotation for small nuclear RNA pseudogenes and conform with gene records such as GeneCards[4]. This target is most appropriately classified as a genomic pseudogene and not a biologically active molecule or therapeutic target.

Other names

RNU6ATAC31PRNA U6atac small nuclear 31, pseudogene